Abstract
<b>OBJECTIVE:</b> Our aim was to measure the transfer of cocaine and its major metabolite benzoylecgonine across the human term placenta. <b>STUDY DESIGN:</b> By means of in vitro perfusion of the human term placental cotyledon the transfer of these compounds was measured. <b>RESULTS:</b> The steady-state maternal-to-fetal transfer of cocaine (0.18 ± 0.05 μg/ml/min) was significantly greater than benzoylecgonine transfer (0.02 ± 0.01 μg/ml/min) (<i>p</i> < 0.05). When the perfused tissue was analyzed 32% ± 7% of the maternal cocaine dose was retained by the placental tissue, whereas only 12% ± 12% of the maternal benzoylecgonine dose was retained by the placental compartment. <b>CONCLUSIONS:</b> These results suggest (1) the placenta may serve as a depot for large amounts of cocaine, thus offering some degree of fetal protection after bolus administration; (2) fetal exposure may be prolonged by placental retention and subsequent release of cocaine and benzoylecgonine; and (3) benzoylecgonine does not cross the placenta as readily as does cocaine. Variability in placental handling of cocaine and benzoyl~cgonine may therefore determine fetal exposure to these agents.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.